Healthcare
China's Canton Biologics raises $41m Series C
Chinese pharmaceutical industry services provider Canton Biologics has completed a CNY 300m (USD 41m) Series C round led by state-owned SDIC Venture Capital.
Hony looks to raise SPAC in Hong Kong
Chinese private equity firm Hony Capital has filed to raise a special purpose acquisition company (SPAC) in Hong Kong, having previously failed to get traction with a similar structure in the US.
Hong Kong virtual insurer Bowtie gets $35m Series B
Hong Kong digital life insurance company Bowtie has closed a USD 34.9m Series B round led by the local unit of Sun Life Financial.
Lion X, Vickers lead Series B for Singapore's Awak
Lion X Ventures and Vickers Venture Partners have led a Series B round of approximately USD 20m for Awak Technologies, a Singaporean start-up that makes wearable dialysis treatment devices.
India healthcare: New momentum, new directions
Private equity has become comfortable with niche segments and regional sub-markets in Indian healthcare services. Technology-based business models are next
Innovation can end China's healthcare downcycle - AVCJ Forum
Investors in Chinese healthcare are looking for innovators with global competencies to lead an industry recovery following a challenging past 12 months, the AVCJ Private Equity & Venture Forum China 2023 heard.
CICC leads $60m Series B for China's Grit Biotechnology
CICC Capital had led a USD 60m Series B round for Grit Biotechnology, a Shanghai-based drug developer that is working on pioneering cancer treatments involving tumour-infiltrating lymphocytes (LIT).
KKR agrees China pharmacy acquisition
KKR has agreed to acquire a majority stake in Chinese pharmacy chain Ruirentang Pharmaceutical Group, according to a filing by a local regulator.
China robot surgery specialist raises $27m
Shanghai-based surgical robot business Ronovo Surgical has raised CNY200m（USD 27m）in an extended pre-Series B round led by NRL Capital.
PEP to buy Australia's Healthia for $168m
Pacific Equity Partners (PEP) has agreed to acquire Healthia, an Australia-based healthcare services provider specialising in physiotherapy, podiatry, and optometry, for an equity value of AUD 260m (USD 168m).
Longreach buys Japanese assisted stretching business
The Longreach Group has acquired Nobitel, a Japanese company that provides one-on-one assisted stretching services aimed in part at the country’s ageing population, for an undisclosed sum.
Qiming, Orbimed lead Series A for China's Epigenic
Qiming Venture Partners and OrbiMed Asia Partners have led a USD 32m Series A round for Chinese gene editing therapy start-up Epigenic Therapeutics.
China's HC Scientific gets $41m Series B extension
Lake Bleu Capital and Guotai Junan Innovation Investment have led a Series B extension of approximately CNY 300m (USD 41m) for HC Scientific, a manufacturer of DNA sequencing devices used in modern agriculture and healthcare.
JIP supports Japan cancer diagnostics joint venture
Japanese private equity firm Japan Industrial Partners (JIP) is participating in a local joint venture with BostonGene, a US-based provider of artificial intelligence-enabled (AI) profiling solutions used to treat cancer patients.
The innovation game: China GPs play safe
China investors have abandoned their previous high-risk-high-return approach in favour of proven business models and profitability. Hotspots like autonomous driving, biotech, and SaaS are no exception
Deal focus: Longreach hits homerun with Quasar
The Longreach Group transitioned Quasar Medical to professional management, took it into new markets, and diversified the company’s manufacturing footprint. A 7x return was its reward
TPG, Temasek add $80 to India's Dr Agarwal's
TPG Growth and Temasek Holdings are funding a USD 80m expansion drive for existing investee Dr Agarwal’s Eye Hospital that will see the Indian eyecare chain double its footprint to 300 hospitals.
Singapore's Jungle absorbs healthcare specialist HealthXCapital
Singapore’s Jungle Ventures has ramped up its healthcare investment capacity by combining with local sector specialist HealthXCapital (HXC).
IFC to back India's Wellspring Healthcare
The International Finance Corporation (IFC) is set to invest USD 11m in India’s Wellspring Healthcare, which operates 17 primary care clinics in Mumbai and Pune.
AGIC backs Singapore medical device manufacturer
Hong Kong-headquartered AGIC Capital, an Asia-Europe cross-border specialist, has led a growth equity round of undisclosed size for Singapore-based medical devices maker AP Technologies.
China's Leadsynbio raises Series D
Chinese synthetic biology company Leadsynbio has raised a Series D round of unspecified size from existing investors Lilly Asia Ventures and Sherpa Healthcare Partners.
Singapore's Quadria secures $200m 'social' credit facility
Singapore-based healthcare specialist Quadria Capital has secured a revolving credit facility of up to USD 200m for investments deemed “social projects.”
China's Neurophth Biotechnology gets $97m Series C extension
Neurophth Biotechnology, a China-based gene therapy developer specialising in ocular diseases, has raised nearly CNY 700m (USD 97m) in an extended Series C round.
Bain set for $630m buyout of Australia's Estia Health
Bain Capital has won board approval to acquire Australia-listed aged care provider Estia Health through a scheme of implementation that gives the business an enterprise value of approximately AUD 959m (USD 630m).